Pharma Focus Asia

Repligen

LATEST NEWSRead more...

23

Jul 2024

MasterControl Introduces GxPAssist AI to Enhance Life Science Processes

MasterControl a leader in manufacturing and quality management software for regulated industries has introduced GxPAssist AI a suite of generative artificial intelligence AI tools designed to optimize processes for quality and manufacturing professionals These tools aim to enhance efficiency and ens...

23

Jul 2024

FDA Grants Approval for Samsung Bioepis’ EPYSQLI® as a Biosimilar to Soliris®

Samsung Bioepis Co Ltd has received FDA approval for EPYSQLI eculizumabaagh as a biosimilar to Soliris eculizumab EPYSQLI is indicated for treating paroxysmal nocturnal hemoglobinuria PNH to reduce hemolysis and atypical hemolytic uremic syndrome to inhibit complementmediated

22

Jul 2024

Everest Medicines Begins Dosing in China for Global Phase 2b Trial of Zetomipzomib for Lupus Nephritis

Everest Medicines has announced the dosing of the first Chinese patient with zetomipzomib in the global Phase b PALIZADE trial targeting active lupus nephritis Zetomipzomib

22

Jul 2024

Innovent Announces Successful Phase 3 Trial Results for Mazdutide in Type 2 Diabetes Patients in China and Plans to Submit NDA to NMPA

Innovent Biologics Inc a leading biopharmaceutical firm focusing on treatments for oncology autoimmune conditions cardiovascular diseases metabolic disorders and ophthalmology

20

Jul 2024

Shenzhen Chipscreen Biosciences Co., Ltd. Receives NMPA Approval for Chiglitazar-Metformin Combination Therapy for Type 2 Diabetes

Shenzhen Chipscreen Biosciences Co Ltd has announced that the National Medical Products Administration has granted a Drug Registration Certificate for Chiglitazar a novel

19

Jul 2024

Pluri CDMO Selected to Produce Kadimastem's Novel Cell Therapy Products

Pluri Inc a leader in biotechnology has entered into a technology transfer and manufacturing agreement with Kadimastem Ltd a clinicalstage biotechnology company focused on developing cell therapies for ALS and diabetes Through its PluriCDMO division launched earlier this year Pluri will utilize

Solovpe

press releasesRead more...

23

Jul 2024

QDX Announces Collaboration with Prelude Therapeutics on Novel Oncology Programs

QDX a computational drug discovery company today announced a collaboration with Prelude Therapeutics a clinicalstage precision oncology company targeting undisclosed previously undrugged

23

Jul 2024

GC Cell and Lukas Announce Strategic Cooperation Agreement to Jointly Tap into the Innovative Cell Therapy including and beyond Korean and Taiwanese Market

GC Cell Corporation and Lukas Biomedical Co Ltd has formally signed an international strategic cooperation agreement GC Cell is a fully integrated pioneer in cell and gene therapy

22

Jul 2024

Biophytis Deploys its Partnership Strategy and Signs Two Contracts with Local Agents in Asia

Biophytis SA a clinicalstage biotechnology company specializing in the development of treatments for agerelated diseases today announces the deployment of its partnership

22

Jul 2024

Astellas and Graduate School of Medicine / Faculty of Medicine, Osaka University Enter into Research Collaboration to Develop Pluripotent Stem Cell-Derived Cartilage Organoid Cell Therapy

Astellas Pharma Inc and Graduate School of Medicine Faculty of Medicine Osaka University today announced that Astellas Institute for Regenerative Medicine

20

Jul 2024

Teva Announces First Phase 3 Evidence of Efficacy and Safety of an Anti-CGRP Monoclonal Antibody in Children in AJOVY® (fremanezumab) SPACE Trial for Prevention of Episodic Migraine

Teva Pharmaceutical Industries Ltd announced today positive topline results from its Phase SPACE study evaluating the efficacy of AJOVY for the prevention of episodic migraine in children

19

Jul 2024

Analytica Vietnam 2025 Set to Be the Biggest Yet With 85% of Exhibition Halls Sold Out

The th edition of analytica Vietnam scheduled to take place from April at the Saigon Exhibition and Convention Center SECC in Ho Chi Minh City will bring together leading experts

30 - 01

Jul 2024

30 - 01

Jul 2024

chemical indonesia

jakarta barat, Indonesia

30 - 01

Jul 2024

Inalab 2023

Jakarta Barat, Indonesia

13 - 14

Aug 2024

ADVANCING BUSINESS, TECHNOLOGY AND INNOVATION

Songdo Convensia, Incheon, South Korea

13 - 14

Aug 2024

12 YEARS OF EXCELLENCE: SOUTH KOREA’S BIOLOGICS

Songdo Convensia, Incheon, South Korea

19 - 21

Aug 2024
Hexagon - Expert Insights Webinar
MFA + MMA 2024
4th Annual Cleaning Validation 2024
2nd Annual Pharma Impurity Conclave 2024
CPHI Korea 2024
World Orphan Drug Congress Europe 2024
Thermo Fisher - Drug Discovery and the impact of mAbs

TOP ARTICLES

  • 5

    3D Printing Revolutionising Nanotechnology

    Mansi Athalye

    Assistant Professor , Department of Pharmaceutics at L. M. College of Pharmacy

    Sagar Popat

    Research Student, Pursuing M. Pharmacy, Pharmaceutics, L. M. College of Pharmacy

KNOWLEDGE BANK

  • Interviews

    Life Sciences - Clinical, TNT Asia

    Director

    Clinical trials have very detailed and precise processes and the logistical elements of these processes are critical Recent revisions to the pharmaceutical industrys regulatory laws as well as improved patent laws in countries such as Japan China and India have led to the burgeoning clinical trials market in Asia
  • Articles

    When Orphan Drugs Make All the Difference

    Orphan drugs those medications that are typically produced in small quantities for limited patient populations are growing in importance worldwide Once largely considered too costly to produce given the limited number of patients affected by a particular disease new technology and new breakthroughs in biopharma have changed the landscape allowing more orphan dru

  • White Papers

    Rx-360 White Paper on Traceability Data Exchange Architecture

    With the quickening pace of global pharmaceutical regulatory drug serialization and traceability mandates the Rx Traceability Data Exchange and Architecture Workgroup TDEA began its activities in August of hosting a series of weekly conference calls to gather information and opinions from participants on supply chain data architecture and choreography models This white paper is the first step in...

EDITORIAL SECTION